Invasive Prenatal Testing Decisions in Pregnancy After Infertility

NCT00341822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-07-02

No results posted yet for this study

Summary

This study will explore the decision-making experiences of women who are currently pregnant following a period of infertility on whether or not to undergo an invasive prenatal test (IPT) procedure, such as amniocentesis or chorionic villus sampling. Women who become pregnant after infertility often experience heightened anxiety regarding the outcome of the pregnancy. When choosing whether or not to have IPT they are faced with a complex decision, set in the unique context of a pregnancy that they often perceive as exceptionally precarious.

Women who are pregnant with their first child after a period of infertility and have made a decision regarding whether or not to undergo IPT may be eligible for this study.

Participants complete an online password-protected questionnaire that measures infertility and decision-making variables and explores women's perceptions of the impact of infertility on their IPT decision-making process. The questionnaire covers the following areas:

* Subject's demographic information, such as age, marital status, number of children, education, race, ethnicity
* Subject's infertility history
* Subject's thoughts and feelings about infertility
* Subject's thoughts and concerns about other people's (e.g., husband, doctor, other infertile women) opinions about IPT
* Subject's decision about whether or not to have IPT and her feelings regarding the decision
* The effect of subject's infertility history on her decision to have or not have IPT

Conditions

  • Pregnancy

Sponsors & Collaborators

  • National Human Genome Research Institute (NHGRI)

    lead NIH

Eligibility

Min Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-29
Completion
2007-12-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00341822 on ClinicalTrials.gov